Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response.

Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ.

PLoS Pathog. 2010 Feb 12;6(2):e1000768. doi: 10.1371/journal.ppat.1000768.

2.

Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.

Tewalt EF, Grant JM, Granger EL, Palmer DC, Heuss ND, Gregerson DS, Restifo NP, Norbury CC.

PLoS Pathog. 2009 May;5(5):e1000457. doi: 10.1371/journal.ppat.1000457. Epub 2009 May 29.

3.

Prolonged antigen presentation following an acute virus infection requires direct and then cross-presentation.

Heipertz EL, Davies ML, Lin E, Norbury CC.

J Immunol. 2014 Oct 15;193(8):4169-77. doi: 10.4049/jimmunol.1302565. Epub 2014 Sep 15.

4.

Systemic toll-like receptor ligation and selective killing of dendritic cell subsets fail to dissect priming pathways for anti-vaccinia virus CD8⁺ T cells.

Wong YC, Smith SA, Tscharke DC.

J Virol. 2013 Nov;87(22):11978-86. doi: 10.1128/JVI.01835-13. Epub 2013 Aug 28.

5.
6.

CD8+ T cell cross-priming via transfer of proteasome substrates.

Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW.

Science. 2004 May 28;304(5675):1318-21.

7.

Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.

Baur K, Brinkmann K, Schweneker M, Pätzold J, Meisinger-Henschel C, Hermann J, Steigerwald R, Chaplin P, Suter M, Hausmann J.

J Virol. 2010 Sep;84(17):8743-52. doi: 10.1128/JVI.00604-10. Epub 2010 Jun 10.

8.

Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.

Busche A, Jirmo AC, Welten SP, Zischke J, Noack J, Constabel H, Gatzke AK, Keyser KA, Arens R, Behrens GM, Messerle M.

J Immunol. 2013 Mar 15;190(6):2767-77. doi: 10.4049/jimmunol.1200966. Epub 2013 Feb 6.

9.

The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.

Iborra S, Izquierdo HM, Martínez-López M, Blanco-Menéndez N, Reis e Sousa C, Sancho D.

J Clin Invest. 2012 May;122(5):1628-43. doi: 10.1172/JCI60660. Epub 2012 Apr 16.

10.

Immunodomination during peripheral vaccinia virus infection.

Lin LC, Flesch IE, Tscharke DC.

PLoS Pathog. 2013;9(4):e1003329. doi: 10.1371/journal.ppat.1003329. Epub 2013 Apr 25.

11.
12.

Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.

Oseroff C, Peters B, Pasquetto V, Moutaftsi M, Sidney J, Panchanathan V, Tscharke DC, Maillere B, Grey H, Sette A.

J Immunol. 2008 Jun 1;180(11):7193-202.

13.

Efficient cross-priming of antiviral CD8+ T cells by antigen donor cells is GRP94 independent.

Lev A, Dimberu P, Das SR, Maynard JC, Nicchitta CV, Bennink JR, Yewdell JW.

J Immunol. 2009 Oct 1;183(7):4205-10. doi: 10.4049/jimmunol.0901828. Epub 2009 Sep 14. Erratum in: J Immunol. 2010 Jul 1;185(1):770.

14.

Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination.

Kastenmuller W, Gasteiger G, Gronau JH, Baier R, Ljapoci R, Busch DH, Drexler I.

J Exp Med. 2007 Sep 3;204(9):2187-98. Epub 2007 Aug 20.

16.

Antigen encoded by vaccine vectors derived from human adenovirus serotype 5 is preferentially presented to CD8+ T lymphocytes by the CD8α+ dendritic cell subset.

Suleman M, Galea S, Gavard F, Merillon N, Klonjkowski B, Tartour E, Richardson J.

Vaccine. 2011 Aug 11;29(35):5892-903. doi: 10.1016/j.vaccine.2011.06.071. Epub 2011 Jul 1.

PMID:
21723900
17.

Induction of CD8+ T-lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus.

Feng CG, Blanchard TJ, Smith GL, Hill AV, Britton WJ.

Immunol Cell Biol. 2001 Dec;79(6):569-75.

19.

Redundancy renders the glycoprotein 96 receptor scavenger receptor A dispensable for cross priming in vivo.

Tewalt EF, Maynard JC, Walters JJ, Schell AM, Berwin BL, Nicchitta CV, Norbury CC.

Immunology. 2008 Dec;125(4):480-91. doi: 10.1111/j.1365-2567.2008.02861.x. Epub 2008 May 15.

20.

The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus.

Zhao Y, De Trez C, Flynn R, Ware CF, Croft M, Salek-Ardakani S.

J Immunol. 2009 May 15;182(10):6278-86. doi: 10.4049/jimmunol.0803682.

Supplemental Content

Support Center